Korea SFDA Finds 14% Of Smallpox Vaccine Stockpile Spoiled
This article was originally published in PharmAsia News
Korea FDA said about 14% of its 7 million doses of smallpox vaccine stockpiled for use in an emergency will have to be destroyed
You may also be interested in...
COVID-19 has shifted consumer health behaviour towards prevention and general wellbeing. However, finding out what consumers actually want and need is still the essence of good OTC innovation, according to Stada Arzneimittel's new vice president of consumer healthcare product development Steve Makin.
Swiss biotech Molecular Partners will receive upfront payment of CHF 60m, including equity.
Just as the MDR and IVDR are being implemented, increasing regulatory divergence in Europe is a growing danger to patient safety throughout the EU, not least through increasing costs and impacting device availability.